REN MANCO

When chemically modified magnetic particles are brought into contact with samples of cancerous cells, telomerase affects the magnetic particles of bioprocesses as well as cancer cells. This increase in magnetic particles of nucleic acids, called telomeres. In this case, however, the base of chemically modified nucleotides incorporated into telomeres. A related site: Jill Schlesinger mentions similar findings. Modified magnetic particles separate from the cancer cells, as well as inclusion for bind a second enzyme, which leads to the formation of light in the system. When this happens, it's a sign that the particles detected cancer.

The method has high sensitivity, which indicates the presence of even small number of cancer cells in pathological samples. It is used successfully to detect cancer in the body. The second method of treating cancer, developed in Israel, with which has been shown the elimination or reduction of tumors in 100 mice. Treatment leads to anti-viral T cells – white blood cells that play a large role in Bodys immune response – detection of tumors, virus-infected cells, and as a consequence of an attack on them. The idea was developed in the Laboratory of Molecular Immunology at the Department of Immunobiology at the Bruce Rappaport Institute of Medical Sciences at the Technion Faculty of Medicine. Approach is to use anti-viral T cells to kill the tumor. The body has a very effective antiviral T cells, as a lifelong subjected to many viruses such as influenza. These cells are very effective for detecting cells which Dont belong to the team genetically engineered a molecule that is naturally found in the body.

On the one hand, the antibody molecules designed to attach to certain types of cancer cells. On the other hand, the team placed molecules called major histocompatibility complex (MHC), which allows T cells to recognize cells themselves. mhc does this through its peptides, small fragments of protein from cells. Many approaches in cancer research have been successful in mice but not humans. However, and firmly believes in this process is non-toxic – unlike chemotherapy and similar procedures – since it is based on natural processes in the immune system. After promising results of clinical trials on mice, researchers have begun to cooperate with the Israeli pharmaceutical company 'Teva' for the development of molecules designed for clinical treatment of cancer in Israel.